DiscoverNPR News NowNPR News: 09-23-2024 10PM EDT
NPR News: 09-23-2024 10PM EDT

NPR News: 09-23-2024 10PM EDT

Update: 2024-09-24
Share

Digest

The podcast begins with a news update from NPR's Jack Spear, covering various stories including deadly airstrikes in Lebanon, the sentencing of a man who opened fire in a Colorado grocery store, and a new advisory from the CDC regarding MPOX. The segment also includes stock market updates. The second segment focuses on the Clinton Global Initiative, highlighting its focus on humanitarian aid and new investments to address the crisis in Sudan. It also reports on promising research regarding an experimental drug, Zatoma last, that may help people with fragile X syndrome, a genetic condition that can cause autism, anxiety, and intellectual disability. The final segment reports on Princess Kate's first public appearance since announcing the completion of her chemotherapy treatment. It highlights her attendance at church with the King and Queen in Scotland and her expected return to public duties.

Outlines

00:00:00
News and Global Initiatives

This segment covers news headlines, including deadly airstrikes in Lebanon and a new CDC advisory on MPOX, followed by discussions on the Clinton Global Initiative's efforts in Sudan and promising research for Fragile X syndrome.

00:04:30
Princess Kate's Recovery and Return to Public Duties

This segment reports on Princess Kate's first public appearance since announcing the completion of her chemotherapy treatment. It highlights her attendance at church with the King and Queen in Scotland and her expected return to public duties.

Keywords

MPOX


MPOX, previously known as Monkeypox, is a viral disease that can cause a rash, fever, and other symptoms. The CDC has issued a new advisory for MPOX, particularly concerning a new strain circulating in Africa.

Fragile X Syndrome


Fragile X syndrome is a genetic condition that can cause autism, anxiety, and intellectual disability. Research suggests that an experimental drug, Zatoma last, may improve cognitive function and social abilities in individuals with fragile X.

Airstrikes in Lebanon


The segment reports on a day of deadly airstrikes in Lebanon, resulting in hundreds of casualties. The strikes are part of an ongoing conflict between Israel and the militant group Hezbollah.

Clinton Global Initiative


The Clinton Global Initiative is a non-profit organization that brings together leaders from various sectors to address global challenges. The initiative focuses on humanitarian aid, investment, and addressing crises like the one in Sudan.

Princess Kate


Princess Kate, the Princess of Wales, has made her first public appearance since completing chemotherapy treatment. She is expected to return to public duties soon.

Q&A

  • What is the new advisory issued by the CDC regarding MPOX?

    The CDC has updated its advice on who should get the MPOX vaccine, now including people who anticipate sexual activity while abroad and are traveling to affected countries like the Democratic Republic of the Congo.

  • What is the experimental drug being researched for its potential to help people with fragile X syndrome?

    The drug, called Zatoma last, was initially developed for Alzheimer's disease but was found to target a brain pathway involved in fragile X. Early evidence suggests it can improve cognitive function and social abilities in individuals with the condition.

  • What is the latest news regarding Princess Kate's health and public appearances?

    Princess Kate has made her first public appearance since completing chemotherapy treatment, attending church with the King and Queen in Scotland. She is expected to return to public duties soon.

Show Notes

NPR News: 09-23-2024 10PM EDT

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

NPR News: 09-23-2024 10PM EDT

NPR News: 09-23-2024 10PM EDT